Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 15901 - 15920 out of 553703 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF01) nivolumab (adm: P) | Opdivo 40 mg/4 mL injection, 4 mL vial | Injection concentrate for I.V. infusion 40 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
Pages
